Skip to content

Evaluation of a new process for chemotherapy prescription and preparation for adult cancer patients attending a day care hospital

Effect of a new process for chemotherapy prescription and preparation on quality of life in adult cancer patients attending a day care hospital.

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616001563459
Acronym
CAPP
Enrollment
300
Registered
2016-11-11
Start date
2017-01-02
Completion date
2018-12-31
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The primary purpose of this study is to improve quality of life of cancer patient coming to the day care clinic in order to receive intravenous chemotherapy. We will modify the process of day cares by performing blood check, consultation, prescription and preparation of the chemotherapy the day before administration. We will also analyze the impovement in workload for pharmacists and nurses. By modifying the whole process, we also expect improvement in term of quality and security for the patient.

Interventions

Patients will be segregated into 2 groups: Group A: experimental group. In this group, patients will have their blood check the day before chemotherapy administration. Later in the day, patients will have either a phone call (for those living more than 35 km away) or a consultation with the oncologist at the clinic (for those living less than 35 km away). After that the oncologist will prescribe the chemotherapy that will be prepared by the pharmacist the day before administration. So in group A

Patients will be segregated into 2 groups: Group A: experimental group. In this group, patients will have their blood check the day before chemotherapy administration. Later in the day, patients will have either a phone call (for those living more than 35 km away) or a consultation with the oncologist at the clinic (for those living less than 35 km away). After that the oncologist will prescribe the chemotherapy that will be prepared by the pharmacist the day before administration. So in group A,blood test, consultation, prescription and chemotherapy preparation all occur on a single day, with chemotherapy administration occurring the following day. Group B: control group. In this group, no modification will be brought to patient care. Meaning: blood check, consultation, prescription ,preparation and administration of the chemotherapy all the same day. All patients attending the day care clinic and all their chemotherapy treatments will be included into the study. The change in our day care clinic organization is definitive. The allocated process will be continued until the end of chemotherapy. The duration of treatment will depend on the chemotherapy regimen choosen for each individual patient.

Sponsors

CHU UCL Namur site Godinne
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

18 years old Cancer patient receiving chemotherapy as an outpatient Given informed consent

Exclusion criteria

Patients included in clinical trials No given informed consent No will to participate

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026